Eledon Pharmaceuticals, Inc. (ELDN): auditor change — Eledon Pharmaceuticals amends 8-K to correct auditor dismissal period; Crowe served only FY 2024

Eledon Pharmaceuticals, Inc.

Corrects prior 8-K that inadvertently referenced Crowe LLP for fiscal year 2023.
Audit Committee dismissed Crowe LLP and engaged Deloitte & Touche LLP on April 1, 2025.
Crowe served as auditor from July 10, 2024 to April 1, 2025; no disagreements or reportable events.
Deloitte engaged as independent auditor for fiscal year ending December 31, 2025.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Eledon Pharmaceuticals, Inc. dismissed Crowe LLP as its auditor.

Action: dismissal
Auditor: Crowe LLP
Successor: Deloitte & Touche LLP

Exact text from the filing

-K, which inadvertently also referenced Crowe LLP with respect to matters related to the Company’s fiscal year ended December 31, 2023. The Company has not made any other changes to the Original 8-K. Item 4.01 Changes in Registrant’s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm. The Audit Committee of the Board of Directors (the “Audit Committee”) of the Company approved the dismissal of Crowe LLP (“Crowe”) as the Company’s independent registered public accounting firm and dismissed Crowe on April 1, 2025. Crowe served as the Company’s independent registered public accounting firm from July 10, 2024 to April 1, 2025.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Eledon Pharmaceuticals, Inc. engaged Deloitte & Touche LLP as its auditor.

Action: engagement
Auditor: Deloitte & Touche LLP

Exact text from the filing

On April 1, 2025, the Audit Committee approved the engagement of Deloitte & Touche LLP

View on SEC.gov

Browse all auditor changes →

Eledon Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-053765

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.